Chimeric Antigen Receptor Delivery Approaches in the Era of Regulatory-Approved T-cell Products for Cancer Immunotherapy

Files

tms-3-1-131916.pdf (83.75 KB)

Date

Authors

Setareh Dashti Shokoohi

Pouya Safarzadeh Kozani

Pooria Safarzadeh Kozani

Mehdi Rabiee Valashedi

Amirsadegh Nikoo

Abdolkarim Sheikhi

Publisher

Brieflands

DOI

https://doi.org/10.5812/tms-131916

Abstract

This article does not have an abstract.

URI

https://brieflands.com/journals/jai/articles/131916

Collections

Trends in Medical Sciences